Artificial intelligence, robotics and gene editing are moving from research demonstrations into products that can alter how people work, manufacture goods and receive treatment. By 2030, the most consequential businesses may be those that turn technical capability into dependable, affordable systems. That creates opportunities across computing, industrial automation and biotechnology, but a technology changing the world does not automatically make its developer a rewarding stock...
